Study of the metformin effect on the survival and recovery rate of patients with COVID-19
Phase 3
- Conditions
- corona virus.
- Registration Number
- IRCT20160310026998N10
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
All patients with Covid-19 symptoms in patients with the history of close contact with suspected people in the last 14 days
fever
pulmonary involvement
normal or reduced cbc
reduced lymphocyte
positive PCR
Exclusion Criteria
patients with type I diabetes
Ketoacidosis
decompensated heart failure
severe rebal failure (GFR<30 ml/min)
metabolic acidosis
immediate need for intubation
severe respiratory failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decreased need to hospitalization. Timepoint: 2 weeks. Method of measurement: obsevation.;Decreased mortality. Timepoint: 2 weeks. Method of measurement: observation.
- Secondary Outcome Measures
Name Time Method